Temasek Holdings (Private) Ltd - ASLAN PHARMACEUTICALS LTD ownership

ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 8 filers reported holding ASLAN PHARMACEUTICALS LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Temasek Holdings (Private) Ltd ownership history of ASLAN PHARMACEUTICALS LTD
ValueSharesWeighting
Q4 2022$604,107
-39.9%
1,678,0750.0%0.00%
-33.3%
Q3 2022$1,004,664
+20.9%
1,678,0750.0%0.01%
+20.0%
Q2 2022$830,647
-45.0%
1,678,0750.0%0.01%
-16.7%
Q1 2022$1,509,764
-19.7%
1,678,0750.0%0.01%
-14.3%
Q4 2021$1,879,000
-37.1%
1,678,0750.0%0.01%
-30.0%
Q3 2021$2,987,000
-46.1%
1,678,0750.0%0.01%
-47.4%
Q2 2021$5,538,000
-1.5%
1,678,0750.0%0.02%
-13.6%
Q1 2021$5,622,000
+83.1%
1,678,0750.0%0.02%
+69.2%
Q4 2020$3,071,000
+13.6%
1,678,075
+18.0%
0.01%
-7.1%
Q3 2020$2,703,000
-5.0%
1,422,4750.0%0.01%
-17.6%
Q2 2020$2,845,000
+96.1%
1,422,4750.0%0.02%
+54.5%
Q1 2020$1,451,000
-49.8%
1,422,4750.0%0.01%
-42.1%
Q4 2019$2,888,000
+17.4%
1,422,4750.0%0.02%
+5.6%
Q3 2019$2,461,000
-43.6%
1,422,4750.0%0.02%
-41.9%
Q2 2019$4,367,000
-28.4%
1,422,4750.0%0.03%
-26.2%
Q1 2019$6,102,000
+19.2%
1,422,4750.0%0.04%
+20.0%
Q4 2018$5,121,000
-54.9%
1,422,4750.0%0.04%
-47.0%
Q3 2018$11,351,000
-10.3%
1,422,4750.0%0.07%
-1.5%
Q2 2018$12,660,0001,422,4750.07%
Other shareholders
ASLAN PHARMACEUTICALS LTD shareholders Q2 2019
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,017,971$2,066,0000.49%
DAFNA Capital Management LLC 117,682$239,0000.08%
Temasek Holdings (Private) Ltd 1,422,475$2,888,0000.02%
PLATINUM INVESTMENT MANAGEMENT LTD 415,450$843,0000.02%
Virtu Financial LLC 54,386$110,0000.01%
MARSHALL WACE, LLP 96,095$195,0000.00%
UBS Group AG 150$00.00%
DEUTSCHE BANK AG\ 2,151$4,0000.00%
MORGAN STANLEY 18,582$37,0000.00%
BANK OF MONTREAL /CAN/ 10,000$20,0000.00%
View complete list of ASLAN PHARMACEUTICALS LTD shareholders